Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.5 (
RNase P
)
1,348
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have constructed a strain (CT1) that expresses
RNase P
conditionally with the aim to analyze the in vivo tRNA processing pathway and the biological role that
RNase P
plays in Synechocystis 6803. In this strain, the rnpB gene, coding for the RNA subunit of
RNase P
, has been placed under the control of the petJ gene promoter (P(petJ)), which is repressed by
copper
, cell growth, and accumulation of
RNase P
RNA is inhibited in CT1 after the addition of
copper
, indicating that the regulation by
copper
is maintained in the chimerical P(petJ)-rnpB gene and that
RNase P
is essential for growth in Synechocystis. We have analyzed several RNAs by Northern blot and primer extension in CT1. Upon addition of
copper
to the culture medium, precursors of the mature tRNAs are detected. Furthermore, our results indicate that there is a preferred order in the action of
RNase P
when it processes a dimeric tRNA precursor. The precursors detected are 3'-processed, indicating that 3' processing can occur before 5' processing by
RNase P
. The size of the precursors suggests that the terminal CCA sequence is already present before
RNase P
processing. We have also analyzed other potential
RNase P
substrates, such as the precursors of tmRNA and 4.5 S RNA. In both cases, accumulation of larger than mature size RNAs is observed after transferring the cells to a
copper
-containing medium.
...
PMID:Conditional expression of RNase P in the cyanobacterium Synechocystis sp. PCC6803 allows detection of precursor RNAs. Insight in the in vivo maturation pathway of transfer and other stable RNAs. 1138 89